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Abstract
Introduction: Although depression and anxiety have been widely investigated among patients with chronic obstructive pulmonary 
disease (COPD), experiencing stressful life events and its effect on increasing risk of exacerbations was rarely assessed. This 
study aimed to clarify the association between facing with stressful events among COPD patients and their disease severity 
leading to hospitalization.
Material and methods: A prospective study was conducted among 128 COPD patients from the population of Qazvin, a north-
west, industrialized city of Iran from December 2017 to December 2018. Patients were followed up for one-year and their related 
measures were gathered. To compare variables among patients stratified by reporting stressful life conditions, Pearson’s chi- 
-square and Fisher’s exact tests were used. Furthermore, to assess the effect of several covariates on the response variable, 
a logistic regression modelling was applied. Results were reported in form of odds ratios and their 95% confidence intervals.
Results: Study findings affirmed that patients who had experienced stressful situation had lower BMI, were retired, experienced 
more frequent exacerbations, and reported higher levels of anxiety/ depression. Moreover, those with stressful conditions were 
among current or former smokers (p < 0.05). Logistic regression analysis revealed that facing with stressful situations was 
significantly associated with the severity of COPD disease (OR 1.9; 95% CI 2.5 to 5.6), smoking habit (OR 2.8; 95% CI 1.6 to 4.2; 
OR 1.5; 95% CI 1.4 to 2.2), and hospitalization during one-year follow up (OR 1.2; 95% CI 1 to 3.3). 
Conclusions: To improve health outcomes of COPD patients, close attention should be given to their psychological disorder and 
appropriate strategies should be applied to reduce patients’ exposure to stressful life events and subsequent anxieties. 
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Introduction
Chronic obstructive pulmonary disease 
(COPD) is defined as a disease leading to reduced 
air flow in pulmonary function, and shortness 
of breath which is largely due to an exposure to 
irritants like air pollution, noxious particles or 
tobacco smoking [1, 2]. It is anticipated that the 
disease will have become the fourth prominent 
death cause and the seventh prominent factor of 
disability worldwide by 2030. High blood pres-
sure, diabetes mellitus, lung cancer, ischemic 
heart disease, anxiety disorder, and depression 
are among important comorbidities for advanced 
COPD. Literature has affirmed that COPD patients 
who suffer from comorbidities are more likely 
to be hospitalized in a frequent manner [3]. Psy-
chological issues like anxiety and depression 
are key factors which cause significant burden 
of mortality, and morbidity, among patients [4]. 
Indeed, patients with symptoms of depression 
experience more frequent hospitalization, failure 
in smoking cessation, and worse prognosis of the 
disease. Furthermore, such mental disorders might 
lead to desperateness, and distress among patients 
which subsequently would lead to a defective 
cycle that perpetuates anxiety and depression [5, 
6]. Thus, addressing psychological disorders in 
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the clinical management of COPD has got a great 
importance, though still little is known about the 
diagnosis and management strategies of such dis-
orders and their impact on COPD patients’ health 
status. In a study conducted by Gianjoppe-Santos 
to compare anxiety and depression symptoms 
between patients in stable and post-exacerbated 
groups, findings revealed that the latter group 
of patients experienced more anxiety symptoms 
compared to the former one [7]. Furthermore, some 
of the studies have surveyed the potential relation-
ships between psychological distress, and COPD 
exacerbation. Almost all the studies affirmed that 
patients with depression or potential anxiety faced 
with more exacerbations and subsequent hospital-
ization [8–10]. Similarly, Laurin et al. found that 
patients with anxiety and depressive disorders 
were at higher risk of exacerbation [11].
Identification of these influencing factors em-
powers policy makers to develop more effective 
strategies for the disease management. Although 
depression and anxiety have been widely in-
vestigated in patients with chronic obstructive 
pulmonary dis ease, experiencing stressful life 
events and its effect on increasing risk of exacer-
bations or death was rarely assessed [12, 13]. Due 
to lack of evidence about the impact of stressful 
life events on patient health out comes in cohort 
studies, mainly in Iran, this study aimed to clar-
ify the association between facing with stressful 
events among COPD patients and their disease 
severity leading to hospitalization.  
Material and methods
Study design, participants and ethics
This was a prospective study conducted 
among 128 patients with COPD who referred to 
an outpatient pulmonary clinic in Qazvin, Iran 
between December and June 2018. Patients aged 
over 40 years old, with a COPD diagnosis accord-
ing to Global Initiative for Chronic Obstructive 
Lung Disease (GOLD) guidelines were included 
in the study (n = 146); among which 18 patients 
excluded from the research due to having con-
current pulmonary disease, or taking drugs other 
than those for COPD. Finally, 128 patients (78.1% 
male, mean age 65.3 ± 11.9) were enrolled. The 
patients were followed up for a year and their 
related measures were gathered and recorded 
during this period of time. 
Ethics statement
The ethics committee of Qazvin University of 
Medical Sciences approved the study, and written 
informed consent was obtained from each of the 
participants.
Measurements
Hospital Anxiety and Depression Scale 
(HADS) was used to measure anxiety/ depression 
among patients. The 7-item subscale with a score 
scale ranging from 0 to 21 has been previously 
used in several studies and was proved to have 
validity and reliability [8, 14]. According to de-
fined cut-off points, those who got score under 
11, were regarded to have low level of anxiety, 
while patients with 11 to 14 score were mentioned 
in moderate and those with 15 to 21 score were 
categorized in severe anxiety group. 
Besides assessing patients’ anxiety, re-
searchers asked a number of questions to assess 
stressful situations which patients faced with 
during 1-year follow up. The questions were 
mainly about the issues including losing a fam-
ily member, patient’s disability due to severe 
illness, lack of adequate support from relatives 
and friends, financial difficulties, retirement, 
and divorce. They also asked the patients to try 
to recall the date/month/year of the occurrence 
of the events.
Statistical analysis
Statistical analysis was conducted using 
Stata software, version 12.0. Patients’ charac-
teristics including their age, BMI, educational 
level, profession, and living situation, also their 
mean HADS score comprised of depression and 
anxiety were calculated for each of the patients 
based on their exposure to stressful life situa-
tions. Furthermore, for each patient who had at 
least one distressful situation during 1-year pe-
riod of follow-up time, number of exacerbations 
was calculated. To compare variables among 
patients stratified by reporting stressful life con-
ditions, Pearson’s chi-square and Fisher’s exact 
tests were used. 
Finally, using a logistic regression modelling, 
the impact of exposure to stressful situations on 
some of the measures including disease severity, 
smoking behavior, and hospitalization was as-
sessed. For all analyses, P < 0.05 was considered 
statistically significant.
Results
This study included and followed 128 pa-
tients for a year. Table 1 depicts the characteris-
tics of study participants based on their hospi-
talization during the follow-up period. Results 
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affirmed that the mean age of patients who were 
hospitalized was slightly higher (65.5 ± 11.3 ver-
sus 62.4 ± 12.6). In relation to smoking, 30% of 
patients who continued smoking at the time of 
study experienced at least one hospitalization. 
Furthermore, 12.64% of patients with severe 
COPD and 14.2% with comorbidity faced with the 
disease exacerbation leading to hospitalization. 
Average score of anxiety and depression among 
patients who reported hospitalization during 
1-year period was respectively 18.7 ± 10.2 and 
17.1 ± 8 confirming higher levels of psychological 
disorder among these patients (p < 0.05). 
In the second step, stressful conditions which 
patients were facing during the follow up period 
of time, were assessed. Table 2 shows patients’ 
characteristics based on their report of stressful 
life events. Overall, seventy percent of patients 
declared that they had encountered with at least 
one stressful and distressing situation during the 
last year. Those who had experienced stressful 
situation had lower BMI, were retired, lived 
alone, experienced more frequent exacerbations, 
and reported higher levels of anxiety/ depression. 
Moreover, those with stressful conditions were 
among current or former smokers (p < 0.05). 
Table 1. Patients’ characteristics based on reporting stressful situations
Characteristics 
Encountered with stressful situation
p-value
Yes No
Age, mean [SD] 63 (10.7) 62.7 (18.5) 0.21
BMI, mean [SD] 25.2 (12.5) 24.9 (9.8) 0.04
Education, n [%] Diploma 27 (30) 26 (70) 0.15
University degree 63 (70) 12 (30)
Smoking status, n [%] Smoker 20 (22) 7 (18) < 0.001
Former smoker 64 (71.7) 24 (64)
Non-smoker 6 (6.3) 7 (18)
Living condition, n [%] Alone 67 (25) 10 (25) 0.12
With family 23 (75) 28 (75)
Occupation, n [%] Employed 18 (20) 6 (15) 0.01
Un-employed 13 (15) —
Retired 59 (65) 32 (85)
Number of exacerbations, n [%] 0 20 (22.3) 18 (47.9) < 0.001
≥ 1 70 (77.7) 20 (52.1)
HADS anxiety, mean [SD] 12.2 (7.7) 10.7 (6.9) < 0.001
HADS depression, mean [SD] 14.5 (6.5) 11.1 (5.7) < 0.001
BMI — body mass index; HADS — Hospital Anxiety and Depression Scale
Table 2. Patients’ health outcomes and behavior based on reporting stressful situations
Patients’ characteristics Stressful life event reported 
(baseline to follow-up)
Mean (95% CI) p-value




















HADS — Hospital Anxiety and Depression Scale
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Then the impact of exposure to stressful situ-
ations on some of the measures including disease 
severity (FEV1 GOLD measure) was analyzed. Data 
are reported in Table 3. 
Logistic regression analysis revealed that 
facing with stressful situations was significantly 
associated with the severity of COPD disease (OR 
1.9; 95% CI 2.5 to 5.6), smoking habit (OR 2.8; 
95% CI 1.6 to 4.2; OR 1.5; 95% CI 1.4 to 2.2), and 
hospitalization during one-year follow up (OR 
1.2; 95% CI 1 to 3.3). 
Finally, we adjusted the model for age, gen-
der, educational level, occupation, income, and 
smoking history and assessed the impact of 
stressful conditions on the risk of COPD exacer-
bation among study patients. Results are shown 
in Table 4.  
After adjusting the model for mentioned 
variables, results revealed that patients who faced 
with stressful situations were 2.8 times more 
likely to be hospitalized due to exacerbation (OR 
2.28; 95% CI 1.04 to 2.84). 
Discussion 
In our study, we found that experiencing 
stressful life events is associated with COPD 
exacerbation. This finding emphasizes on the 
importance of psychological factors in COPD 
patients which has been similarly confirmed in 
several studies. Literature highlights that patients 
with psychological stress may reveal unhealthier 
behaviors which ultimately worsens their health 
condition and increases the risk of COPD exacer-
bation [15]. In a survey conducted by Yohannes et 
al., results revealed higher rate of hospitalization 
among depressed patients [16]. Similar studies 
also affirmed significant associations between 
psychological disorder and exacerbation leading 
to disease-related hospitalizations. This suggests 
that COPD patients are more in danger when 
experiencing stressful events [11, 17].
Regarding this issue, Xu et al. reported that 
after one-year follow up, patients with some 
degrees of anxiety and depression encountered 
significantly more exacerbations and subsequent 
hospitalizations [18]. These findings were in 
line with Laurin et al. report emphasizing on 
a significant association between psychological 
distress and higher rates of exacerbations [11]. 
However, Fan and colleagues stated that using 
various types of cut-off scores through the Beck 
Depression Inventory leads to different find-
ings. In fact, analysis of depressive symptoms as 
continuous predictors is not going to be associ-
ated with hospitalizations. While, using quantile 
measurements approves the relationship between 
depressive symptoms and higher risk of COPD-re-
Table 3. Univariate analysis to compare patients experiencing hospitalization during one-year follow-up
HospitalizationCharacteristics
95% CIORPYesNoCategorical variables
0.83–2.61.20.119 (9)91 (91)MaleGender, n [%]
0.92–4.41.10.259 (7.4)112 (92.6)MarriedMarital status, n [%]
0.77–2.020.80.261 (14.2)6 (85.8)University 
degree
Educational level, n [%]
2.1–5.72.9< 0.0019 (30)21 (70)Current smoker, n [%]
0.87–3.081.10.064 (3.12)62 (48.4)ModerateCOPD grade, n [%]
1.12–5.31.20.0014 (3.12)32 (25)Severe
1.38–3.11.5< 0.00112 (9.25)3 (2.34)Very severe
1.17–2.21.3< 0.0016 (14.2)36 (85.8)Comorbidity, n [%]
9.02–2.41.070.5211 (12.3)79 (87.7)YesExperiencing stressful 
life event, n [%]
95% CIORPMean (SD)Mean (SD)Continuous variables
0.77–1.361.120.0765.5 (11.3)62.4 (12.6)Age
0.87–1.00.950.0523.3 (3.8)25.5 (4.9)BMI
1.01–4.81.17< 0.00118.7 (10.2)7 (2.1)HADS anxiety
1.12–3.71.21< 0.00117.1 (8)10.2 (4.5)HADS depression
BMI — body mass index; COPD — chronic obstructive pulmonary disease; HADS — Hospital Anxiety and Depression Scale
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lated hospitalizations [19]. In a study conducted 
by Yu et al. results disclosed that stressful life 
events were significantly related to symptoms 
of depres sion and anxiety among patients. Oth-
erwise, stressful life events were not associated 
with COPD exacerbations which reported to be 
due to the small sample size of study or short 
time frame of follow-up [8]. Similarly, some of 
the researches highlighted that after adjusting 
the model for covariates namely gender, disease 
severity, oxygen use, history of COPD hospital-
ization, and comorbidity the association between 
psychological distress and hospitalizations be-
came non-significant. Such uneven results also 
highpoint the effect of differences in analysis 
methods and use of varying cutoffs.
Our findings also affirmed that facing with 
stressful conditions reinforces the smoking be-
havior as a risk factor for severity of COPD, 
hospitalization and restriction for daily activities 
which could also increase the risk of depression 
or anxiety in patients. In agreement with these 
results, several studies have shown that anxiety 
and depression are associated with feelings of 
desperateness and lack of self-confidence which 
will consequently lead to poor health behaviors 
namely smoking or physical inactivity [16, 20]. 
Andrenas et al. ascertained that most of the 
patients evaluated their stressful situation as 
a threat, and challenging issue which inversely 
affects their coping skills with distressful disor-
ders [21]. They also believed that such worrying 
conditions have a harmful effect on patients’ 
mental health and their quality of life [22–24]. 
Literature also revealed that deterioration in the 
immune system of patients with anxiety and de-
pression is more likely which eventually weakens 
their resistance toward pathogens [25–27]. 
Despite several studies conducted to ex-
plore the relationship between the experience of 
stressful situations and increased risk of COPD 
exacerbation, our research tried to obtain more 
robust findings through applying a prospective 
study design and choosing shorter time frame for 
asking patients to recall their stressful life expe-
riences. In our study, stressful situations were 
asked monthly from patients and documented 
through a prospective approach. Otherwise, there 
are some limitations regarding the current study. 
First, we were dependent on a self-reported scale 
which identified exposure to stressful conditions 
based on patients’ perception. 
Conclusions
In conclusion, our study found that experi-
encing stressful conditions was connected with 
more anxious and depressing signs among COPD 
patients which ultimately worsened the disease 
severity. Thus, to improve health outcomes of 
COPD patients, close attention should be given 
to their psychological disorder and appropriate 
strategies should be applied to reduce patients’ 
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